These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33832568)

  • 1. What May Be the First Phase 4 Experience with BYFAVO (Remimazolam).
    Henson KS; Thompson KJ
    AANA J; 2021 Apr; 89(2):101-102. PubMed ID: 33832568
    [No Abstract]   [Full Text] [Related]  

  • 2. Remimazolam (Byfavo) for short-term procedural sedation.
    Med Lett Drugs Ther; 2022 Feb; 64(1644):26-28. PubMed ID: 35171895
    [No Abstract]   [Full Text] [Related]  

  • 3. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A miniature pig model of pharmacological tolerance to long-term sedation with the intravenous benzodiazepines; midazolam and remimazolam.
    Io T; Saunders R; Pesic M; Petersen KU; Stoehr T
    Eur J Pharmacol; 2021 Apr; 896():173886. PubMed ID: 33493482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy.
    Rex DK; Bhandari R; Desta T; DeMicco MP; Schaeffer C; Etzkorn K; Barish CF; Pruitt R; Cash BD; Quirk D; Tiongco F; Sullivan S; Bernstein D
    Gastrointest Endosc; 2018 Sep; 88(3):427-437.e6. PubMed ID: 29723512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remimazolam for anaesthesia or sedation.
    Sneyd JR; Rigby-Jones AE
    Curr Opin Anaesthesiol; 2020 Aug; 33(4):506-511. PubMed ID: 32530890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase IIa, randomized, double-blind study of remimazolam (CNS 7056) versus midazolam for sedation in upper gastrointestinal endoscopy.
    Borkett KM; Riff DS; Schwartz HI; Winkle PJ; Pambianco DJ; Lees JP; Wilhelm-Ogunbiyi K
    Anesth Analg; 2015 Apr; 120(4):771-80. PubMed ID: 25502841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy.
    Pambianco DJ; Borkett KM; Riff DS; Winkle PJ; Schwartz HI; Melson TI; Wilhelm-Ogunbiyi K
    Gastrointest Endosc; 2016 May; 83(5):984-92. PubMed ID: 26363333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy.
    Pastis NJ; Yarmus LB; Schippers F; Ostroff R; Chen A; Akulian J; Wahidi M; Shojaee S; Tanner NT; Callahan SP; Feldman G; Lorch DG; Ndukwu I; Pritchett MA; Silvestri GA;
    Chest; 2019 Jan; 155(1):137-146. PubMed ID: 30292760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys.
    Kops MS; Pesic M; Petersen KU; Schmalix WA; Stöhr T
    Eur J Pharmacol; 2021 Jan; 890():173639. PubMed ID: 33065095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-sleeping after reversal of remimazolam by flumazenil.
    Yamamoto T; Kurabe M; Kamiya Y
    J Anesth; 2021 Apr; 35(2):322. PubMed ID: 33687549
    [No Abstract]   [Full Text] [Related]  

  • 15. Electroencephalogram inability to detect intraoperative awakening in a patient with remimazolam tolerance.
    Kawashima S; Kinoshita H; Kawashima W; Nakajima Y
    Minerva Anestesiol; 2023 May; 89(5):482-483. PubMed ID: 36383081
    [No Abstract]   [Full Text] [Related]  

  • 16. Remimazolam anaphylaxis during anesthesia induction.
    Tsurumi K; Takahashi S; Hiramoto Y; Nagumo K; Takazawa T; Kamiyama Y
    J Anesth; 2021 Aug; 35(4):571-575. PubMed ID: 34050439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remimazolam should be antagonized by an adequate flumazenil.
    Sato T; Nishiwaki K
    J Anesth; 2023 Feb; 37(1):164-165. PubMed ID: 36197518
    [No Abstract]   [Full Text] [Related]  

  • 18. Awaiting remimazolam guidance.
    Wootton J; Forrest M
    Br Dent J; 2023 Jan; 234(2):73. PubMed ID: 36707554
    [No Abstract]   [Full Text] [Related]  

  • 19. Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study.
    Tang Y; Yang X; Shu H; Yu Y; Xu J; Pan S; Zou X; Yuan S; Shang Y
    Chin Med J (Engl); 2022 Sep; 135(17):2134-2136. PubMed ID: 36191588
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to remimazolam at a high effect-site concentration.
    Kida K; Taguchi M; Uchiyama K; Fujioka S; Tsubokawa T
    J Anesth; 2023 Feb; 37(1):168-169. PubMed ID: 36449088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.